Skip to main content

Bristol-Myers Squibb

(BMY) - Get Bristol-Myers Squibb Company Report

said the

Food and Drug Administration

TheStreet Recommends

granted approval of a new formulation of Videx, the company's HIV-fighting drug.

The new formulation, Videx EC delayed release capsules, can be taken as a single dose, unlike the previous formulation, which was recommended to be taken twice a day.